Intelligence Platform
Patents
Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9676771
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
granted patentUS 9676846
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted patentUS 9675637
Use of nitrite salts for the treatment of cardiovascular conditions
granted patentUS 9675651
Method for increasing performance of offspring
granted patentUS 9676858
Human bispecific EGFRvIII antibody and CD3 engaging molecules
granted patentUS 9676857
Soluble engineered monomeric Fc
granted patentUS 9669004
Daidzein analogs as treatment for cancer
granted patentUS 9670549
Gene expression signatures of neoplasm responsiveness to therapy
granted patentUS 9662306
Compositions and methods for diagnosis and treatment of metabolic syndrome
granted patentUS 9663485
Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders
granted patentUS 9663521
Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenes
granted patentUS 9657269
Regulatory B cells (tBREGS) and their use
granted patentUS 9657292
Compositions and methods for treating or preventing lupus
granted patentUS 9657096
Human domain antibodies against components of the human insulin-like growth factor (IGF) s
granted patentUS 9657066
Pseudomonas exotoxin A with less immunogenic B cell epitopes
granted patentUS 9655366
Volatile blends and the effects thereof on the navel orangeworm moth
granted patentUS 9650422
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito
granted patentUS 9651462
Method and system for sampling and separating submicron-sized particles based on density a
granted patentUS 9649339
LAT adapter molecule for enhanced T-cell signaling and method of use
granted patentUS 9649343
Compositions and methods for transplantation of colon microbiota
granted patentUS 9650352
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydr
granted patentUS 9642391
Anti-regurgitation composition maintaining gut motility
granted patentUS 9644179
Use of PDL1 expressing cells to convert T cells into regulatory T cells
granted patentUS 9644216
Adeno-associated virus vectors for treatment of glycogen storage disease
granted